6-Benzylamino-7-deazapurine

CAS : 60972-04-5

Ref. 3D-FB04580

Informations sur le produit

• Nom: 6-Benzylamino-7-deazapurine
• Synonymes: 4-Benzylamino-1H-pyrrole[2,3-d]pyrimidine
• Marque: Biosynth
• Description: 6-Benzylamino-7-deazapurine is a drug that has been shown to be effective in the treatment of pancreatic cancer. It is a monomer that reacts with nucleophiles such as 6-mercaptopurine, which are present in the human lung. The reaction generates an exergonic molecule that can be used to generate ATP and regenerate NAD+ during irradiation. This process has been observed using kinetic studies on human colon adenocarcinoma cells. 6-Benzylamino-7-deazapurine can also react with triazole compounds to form a linker and increase the rate of polymerization. The optimization of this reaction time could lead to more efficient cancer treatments.

Propriétés chimiques

• Masse moléculaire: 224.26 g/mol
• Formule: C₁₃H₁₂N₄
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C13H12N4/c1-2-4-10(5-3-1)8-15-13-11-6-7-14-12(11)16-9-17-13/h1-7,9H,8H2,(H2,14,15,16,17)
• Code InChI: InChIKey=XQTDTJWTCBSTMC-UHFFFAOYSA-N
• SMILES: c1ccc(CNc2ncnc3[nH]ccc23)cc1